SCHEMBL649023

SCHEMBL649023

COc1cccc(N=C2NC(=O)C(=Cc3cnc(NC(C)=O)s3)S2)c1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.46
KMT2A Q03164 6/20 0.46
PTP4A3 O75365 1/20 0.45
MAPT P10636 4/20 0.44
NPSR1 Q6W5P4 2/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
MAPK1 P28482 1/20 0.43
GRK6 P43250 1/20 0.42
HSD11B1 P28845 1/20 0.42
KIF11 P52732 1/20 0.41
OGA O60502 2/20 0.41
RNASEL Q05823 2/20 0.40
GALR3 O60755 1/20 0.39
USP2 O75604 1/20 0.39
POLB P06746 1/20 0.39
KDM4E B2RXH2 1/20 0.39
LMNA P02545 1/20 0.39
GAA P10253 1/20 0.39
HPGD P15428 1/20 0.39
HTT P42858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL649022 1.00 MEN1 (0.46) MEN1KMT2APTP4A3MAPTNPSR1
SCHEMBL651553 0.92 MEN1 (0.55) MEN1KMT2APTP4A3MAPTNPSR1
SCHEMBL651554 0.92 MEN1 (0.55) MEN1KMT2APTP4A3MAPTNPSR1
SCHEMBL650933 0.89 MAPT (0.56) MEN1KMT2APTP4A3MAPTNPSR1
SCHEMBL650934 0.89 MAPT (0.56) MEN1KMT2APTP4A3MAPTNPSR1
SCHEMBL650948 0.89 GRK6 (0.48) MEN1KMT2APTP4A3MAPTNPSR1
SCHEMBL650949 0.89 GRK6 (0.48) MEN1KMT2APTP4A3MAPTNPSR1
SCHEMBL649994 0.86 MAPT (0.44) MEN1KMT2AMAPTNPSR1L3MBTL1
SCHEMBL650328 0.86 MAPT (0.44) MEN1KMT2AMAPTNPSR1L3MBTL1
SCHEMBL652202 0.84 MEN1 (0.44) MEN1KMT2APTP4A3MAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119812-B2 Thiazolidinone derivative SBI BIOTECH CO., LTD. (JP) 2012-02-21 US disclosed
US-20110190299-A1 THIAZOLIDINONE DERIVATIVE SBI BIOTECH CO., LTD. (JP) 2011-08-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110190299-A1 THIAZOLIDINONE DERIVATIVE CDC7, CDK17, CDCA2 MEN1 1406/4885KMT2A 3437/4885PTP4A3 1604/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.